Spun out from Abbott Labs in 2004 with a focus on the hospital market, Hospira’s product portfolio includes generic acute care and oncology injectables and integrated infusion therapy and medication management systems. The company operates in 3 geographical segments: Americas; Europe, Middle East and Africa; and Asia Pacific. Its medical device brands include EndoTool, GemStar SP, Hospira MedNet software, LifeCare PCA, LifeShield, Plum A+, Symbiq and TheraDoc. Hospira topped $4 billion in sales in 2012.
Home » Hospira
More recent news
- Cooper Companies continues to see activist pressure to sell divisions, replace CEO
- Cordis earns FDA nod for Selution SLR drug-eluting balloon
- Siemens Healthineers links with Novo to advance liver fibrosis blood test
- GE HealthCare rolls out AI software for predicting care bottlenecks
- Wandercraft’s self-balancing Eve exoskeleton begins US launch
